Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

Detalles Bibliográficos
Autores principales: Trotman, Judith, Presgrave, Peter, Carradice, Duncan P., Lenton, Douglas Stuart, Gandhi, Maher K., Cochrane, Tara, Badoux, Xavier, Carlson, Julia, Nkhoma, Gloria, Butcher, Belinda, Nikpour, Armin, Fulham, Michael, Johnston, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946407/
https://www.ncbi.nlm.nih.gov/pubmed/36844180
http://dx.doi.org/10.1097/HS9.0000000000000836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946407/
https://www.ncbi.nlm.nih.gov/pubmed/36844180
http://dx.doi.org/10.1097/HS9.0000000000000836

Ejemplares similares